These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 32139315

  • 1. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Liu M, Zhong Y, Chen J, Liu Y, Tang C, Wang X, Zhang Y, Wang P, Logan SM, Chen W, Wei B.
    Vaccine; 2020 Mar 23; 38(14):3031-3041. PubMed ID: 32139315
    [Abstract] [Full Text] [Related]

  • 2. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on H. pylori Infection in Mongolian gerbils.
    Guo L, Yang H, Tang F, Yin R, Liu H, Gong X, Wei J, Zhang Y, Xu G, Liu K.
    Front Cell Infect Microbiol; 2017 Mar 23; 7():349. PubMed ID: 28824883
    [Abstract] [Full Text] [Related]

  • 3. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
    Zhong Y, Chen J, Liu Y, Zhang Y, Tang C, Wang X, Wang P, Chen W, Wei B, Liu M.
    Microb Pathog; 2020 Aug 23; 145():104229. PubMed ID: 32353579
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic Protection Against H. pylori Infection in Mongolian Gerbils by Oral Immunization With a Tetravalent Epitope-Based Vaccine With Polysaccharide Adjuvant.
    Guo L, Hong D, Wang S, Zhang F, Tang F, Wu T, Chu Y, Liu H, He M, Yang H, Yin R, Liu K.
    Front Immunol; 2019 Aug 23; 10():1185. PubMed ID: 31191547
    [Abstract] [Full Text] [Related]

  • 5. Protection Against Helicobacter pylori Infection in BALB/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC.
    Pan X, Ke H, Niu X, Li S, Lv J, Pan L.
    Front Immunol; 2018 Aug 23; 9():1003. PubMed ID: 29867978
    [Abstract] [Full Text] [Related]

  • 6. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J, Dai LX, Pan X, Wang H, Li B, Zhu J, Li MY, Shi XL, Wang BN.
    Pathog Dis; 2015 Jul 23; 73(5):. PubMed ID: 25846576
    [Abstract] [Full Text] [Related]

  • 7. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
    Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y.
    Appl Microbiol Biotechnol; 2014 Apr 23; 98(8):3495-507. PubMed ID: 24370888
    [Abstract] [Full Text] [Related]

  • 8. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X, Xing Y, Guo L, Lv X, Song H, Xi T.
    Pathog Dis; 2014 Oct 23; 72(1):78-86. PubMed ID: 24687988
    [Abstract] [Full Text] [Related]

  • 9. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R, Guy B, Thomas WD, Giannasca PJ, Monath TP.
    Infect Immun; 2000 May 23; 68(5):2775-82. PubMed ID: 10768972
    [Abstract] [Full Text] [Related]

  • 10. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L, Yin R, Xu G, Gong X, Chang Z, Hong D, Liu H, Ding S, Han X, Li Y, Tang F, Liu K.
    Helicobacter; 2017 Dec 23; 22(6):. PubMed ID: 28851031
    [Abstract] [Full Text] [Related]

  • 11. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
    Zhou Z, Dong H, Huang Y, Yao S, Liang B, Xie Y, Long Y, Mai J, Gong S.
    J Med Microbiol; 2017 Jan 23; 66(1):83-89. PubMed ID: 27930268
    [Abstract] [Full Text] [Related]

  • 12. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
    Xie W, Zhao W, Zou Z, Kong L, Yang L.
    Helicobacter; 2021 Jun 23; 26(3):e12807. PubMed ID: 33847026
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y, Liu W, Li X, Guo L, Lv X, Xi T.
    Biochem Biophys Res Commun; 2015 Jul 03; 462(3):269-74. PubMed ID: 25957472
    [Abstract] [Full Text] [Related]

  • 14. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L, Liu K, Zhao W, Li X, Li T, Tang F, Zhang R, Wu W, Xi T.
    Appl Microbiol Biotechnol; 2013 Mar 03; 97(6):2367-78. PubMed ID: 23064457
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL.
    Mol Cell Probes; 2014 Feb 03; 28(1):25-30. PubMed ID: 24036137
    [Abstract] [Full Text] [Related]

  • 16. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL, Liu WC, Yang WW, Zhong D, Liu YH, Zhang JD, Jiang JH, Li SS.
    Biomed Environ Sci; 2005 Dec 03; 18(6):411-8. PubMed ID: 16544523
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
    Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Li HX, Zou QM.
    Vaccine; 2009 Aug 06; 27(36):5013-9. PubMed ID: 19446591
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T.
    Appl Microbiol Biotechnol; 2012 Sep 06; 95(6):1437-44. PubMed ID: 22569640
    [Abstract] [Full Text] [Related]

  • 19. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B, Pan X, Wang H, Zhou Y, Zhu J, Yang J, Li W.
    Int J Clin Exp Pathol; 2014 Sep 06; 7(10):6559-66. PubMed ID: 25400734
    [Abstract] [Full Text] [Related]

  • 20. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L, Flach CF, Clements J, Holmgren J, Raghavan S.
    Infect Immun; 2013 May 06; 81(5):1532-40. PubMed ID: 23439305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.